scholarly journals Identification of CENP-V as a novel microtubule-associating molecule that activates Src family kinases through SH3 domain interaction

2009 ◽  
Vol 14 (12) ◽  
pp. 1383-1394 ◽  
Author(s):  
Zen-ichiro Honda ◽  
Takeshi Suzuki ◽  
Hiroaki Honda
2006 ◽  
Vol 281 (37) ◽  
pp. 27029-27038 ◽  
Author(s):  
Ronald P. Trible ◽  
Lori Emert-Sedlak ◽  
Thomas E. Smithgall

PLoS ONE ◽  
2014 ◽  
Vol 9 (8) ◽  
pp. e105629 ◽  
Author(s):  
Jamie A. Moroco ◽  
Jodi K. Craigo ◽  
Roxana E. Iacob ◽  
Thomas E. Wales ◽  
John R. Engen ◽  
...  

2015 ◽  
Author(s):  
Heather L. Rust ◽  
Jamie A. Moroco ◽  
John J. Alvarado ◽  
John J. Engen ◽  
Thomas E. Smithgall

2011 ◽  
Vol 2011 ◽  
pp. 1-14 ◽  
Author(s):  
Banibrata Sen ◽  
Faye M. Johnson

The nonreceptor protein tyrosine kinase Src plays a crucial role in the signal transduction pathways involved in cell division, motility, adhesion, and survival in both normal and cancer cells. Although the Src family kinases (SFKs) are activated in various types of cancers, the exact mechanisms through which they contribute to the progression of individual tumors remain to be defined. The activation of Src in human cancers may occur through a variety of mechanisms that include domain interaction and structural remodeling in response to various activators or upstream kinases and phosphatastes. Because of Src's prominent roles in invasion and tumor progression, epithelial-to-mesenchymal transition, angiogenesis, and the development of metastasis, Src is a promising target for cancer therapy. Several small molecule inhibitors of Src are currently being investigated in clinical trials. In this article, we will summarize the mechanisms regulating Src kinase activity in normal and cancer cells and discuss the status of Src inhibitor development against various types of cancers.


2008 ◽  
Vol 18 (3) ◽  
pp. 1217-1222 ◽  
Author(s):  
Noor Atatreh ◽  
Cvetan Stojkoski ◽  
Phillippa Smith ◽  
Grant W. Booker ◽  
Caroline Dive ◽  
...  

1995 ◽  
Vol 15 (1) ◽  
pp. 186-197 ◽  
Author(s):  
S Richard ◽  
D Yu ◽  
K J Blumer ◽  
D Hausladen ◽  
M W Olszowy ◽  
...  

src family tyrosine kinases contain two noncatalytic domains termed src homology 3 (SH3) and SH2 domains. Although several other signal transduction molecules also contain tandemly occurring SH3 and SH2 domains, the function of these closely spaced domains is not well understood. To identify the role of the SH3 domains of src family tyrosine kinases, we sought to identify proteins that interacted with this domain. By using the yeast two-hybrid system, we identified p62, a tyrosine-phosphorylated protein that associates with p21ras GTPase-activating protein, as a src family kinase SH3-domain-binding protein. Reconstitution of complexes containing p62 and the src family kinase p59fyn in HeLa cells demonstrated that complex formation resulted in tyrosine phosphorylation of p62 and was mediated by both the SH3 and SH2 domains of p59fyn. The phosphorylation of p62 by p59fyn required an intact SH3 domain, demonstrating that one function of the src family kinase SH3 domains is to bind and present certain substrates to the kinase. As p62 contains at least five SH3-domain-binding motifs and multiple tyrosine phosphorylation sites, p62 may interact with other signalling molecules via SH3 and SH2 domain interactions. Here we show that the SH3 and/or SH2 domains of the signalling proteins Grb2 and phospholipase C gamma-1 can interact with p62 both in vitro and in vivo. Thus, we propose that one function of the tandemly occurring SH3 and SH2 domains of src family kinases is to bind p62, a multifunctional SH3 and SH2 domain adapter protein, linking src family kinases to downstream effector and regulatory molecules.


2011 ◽  
Vol 439 (3) ◽  
pp. 505-518 ◽  
Author(s):  
Elena Tibaldi ◽  
Andrea Venerando ◽  
Francesca Zonta ◽  
Carlo Bidoia ◽  
Elisa Magrin ◽  
...  

The association of the SH3 (Src homology 3) domain of SFKs (Src family kinases) with protein partners bearing proline-rich motifs has been implicated in the regulation of SFK activity, and has been described as a possible mechanism of relocalization of SFKs to subcellular compartments. We demonstrate in the present study for the first time that p13, an accessory protein encoded by the HTLV-1 (human T-cell leukaemia virus type 1), binds the SH3 domain of SFKs via its C-terminal proline-rich motif, forming a stable heterodimer that translocates to mitochondria by virtue of its N-terminal mitochondrial localization signal. As a result, the activity of SFKs is dramatically enhanced, with a subsequent increase in mitochondrial tyrosine phosphorylation, and the recognized ability of p13 to insert itself into the inner mitochondrial membrane and to perturb the mitochondrial membrane potential is abolished. Overall, the present study, in addition to confirming that the catalytic activity of SFKs is modulated by interactors of their SH3 domain, leads us to hypothesize a general mechanism by which proteins bearing a proline-rich motif and a mitochondrial localization signal at the same time may act as carriers of SFKs into mitochondria, thus contributing to the regulation of mitochondrial functions under various pathophysiological conditions.


Sign in / Sign up

Export Citation Format

Share Document